MedTherapy Announces Innovative Global Measures to Meet Acute Manufacturing Challenges for ‘CAR-T’ cell gene Therapies to Make them more Affordable and Accessible Worldwide
BOSTON, Jan. 14, 2025 /PRNewswire/ -- MedTherapy, a Boston based Chimeric Antigen Receptor (CAR) -T cell therapy biotechnology company, made its announcements at the JP Morgan Annual Healthcare Conference in